Mersana Therapeutics, Inc.MRSNNASDAQ
LOADING
|||
Switch Symbol:
Operating Income Scaling
Trending higher, above historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-73.34M
↑ 22% above average
Average (9y)
$-93.77M
Historical baseline
Range
High:$-13.82M
Low:$-203.77M
CAGR
+18.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-73.34M | +57.1% |
| 2023 | $-170.96M | +16.1% |
| 2022 | $-203.77M | -20.7% |
| 2021 | $-168.86M | -8.8% |
| 2020 | $-155.15M | -413.7% |
| 2019 | $-30.20M | +54.0% |
| 2018 | $-65.66M | -65.7% |
| 2017 | $-39.62M | -186.6% |
| 2016 | $-13.82M | +15.4% |
| 2015 | $-16.34M | - |